Follow The Filings

OTLK Outlook Therapeutics

Outlook Therapeutics earnings company data as of 7:18 PM ET 8/21

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 14 Aug EPS — -0.15 —
Rev — $10.0K —

Insider trades

Open-market buys and sales by OTLK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OTLK insider trades
  • $7.9M bought by 7 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Lawrence A Kenyon CFO
    Buy
    — 101,010 shares +1699% to stake
    Traded Aug 14 Filed Aug 14
    ↗
  2. Robert Charles Jahr CEO
    Buy
    — 151,515 shares New stake
    Traded Aug 14 Filed Aug 14
    ↗
  3. Ghiath M. Sukhtian Director, +1 joint filer
    Buy
    $2.5M 2,525,252 shares at $0.9900 +11% to stake
    Traded Aug 12 Filed Aug 14
    ↗
  4. Faisal Ghiath Sukhtian Director
    Buy
    $100K 95,398 shares at $1.05 +76% to stake
    Traded Jul 29 Filed Jul 29
    ↗
  5. Yezan Munther Haddadin Director
    Buy
    $24K 29,000 shares at $0.8300 +78% to stake
    Traded Jun 2 Filed Jun 3
    ↗
  6. Ghiath M. Sukhtian Director, +1 joint filer
    Buy
    $5M 8,539,709 shares at $0.5900 +63% to stake
    Traded May 28 Filed Jun 1
    ↗
  7. Faisal Ghiath Sukhtian Director
    Buy
    $50K 122,174 shares at $0.4100 +3593% to stake
    Traded May 27 Filed May 27
    ↗
  8. Yezan Munther Haddadin Director
    Buy
    $15K 34,000 shares at $0.4400 +1074% to stake
    Traded May 26 Filed May 27
    ↗
  9. Randy H Thurman Director
    Buy
    $2,145 5,000 shares at $0.4300 +843% to stake
    Traded May 26 Filed May 27
    ↗
  10. Kurt J Hilzinger Director
    Buy
    $177K 400,000 shares at $0.4400 +1691% to stake
    Traded May 26 Filed May 27
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 3.01 Filing Doc
8-K 8.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
424B3 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
DEFA14A Filing Doc
8-K 3.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEF 14A Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.